KOWALIK, MARTA ANNA
 Distribuzione geografica
Continente #
EU - Europa 94.736
NA - Nord America 4.054
AS - Asia 1.931
SA - Sud America 246
AF - Africa 77
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 101.049
Nazione #
IT - Italia 93.624
US - Stati Uniti d'America 3.966
SG - Singapore 724
CN - Cina 579
SE - Svezia 275
VN - Vietnam 213
BR - Brasile 187
DE - Germania 184
UA - Ucraina 147
GB - Regno Unito 121
FI - Finlandia 117
FR - Francia 84
BD - Bangladesh 68
CA - Canada 61
HK - Hong Kong 58
IN - India 41
TR - Turchia 41
KR - Corea 37
ZA - Sudafrica 31
NL - Olanda 26
PL - Polonia 26
IQ - Iraq 24
AR - Argentina 21
BE - Belgio 20
JP - Giappone 19
MA - Marocco 19
RU - Federazione Russa 19
IR - Iran 18
MX - Messico 16
ES - Italia 15
PK - Pakistan 15
AT - Austria 14
JO - Giordania 11
EC - Ecuador 10
IE - Irlanda 10
MY - Malesia 9
CH - Svizzera 8
CO - Colombia 8
LT - Lituania 8
ID - Indonesia 7
PH - Filippine 7
UZ - Uzbekistan 7
VE - Venezuela 7
IL - Israele 6
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
DK - Danimarca 5
EG - Egitto 5
MT - Malta 5
TN - Tunisia 5
TW - Taiwan 5
AZ - Azerbaigian 4
CL - Cile 4
DZ - Algeria 4
HU - Ungheria 4
JM - Giamaica 4
KE - Kenya 4
KZ - Kazakistan 4
PA - Panama 4
PE - Perù 4
PT - Portogallo 4
AU - Australia 3
CZ - Repubblica Ceca 3
LK - Sri Lanka 3
NG - Nigeria 3
PS - Palestinian Territory 3
PY - Paraguay 3
AL - Albania 2
AM - Armenia 2
BY - Bielorussia 2
ET - Etiopia 2
GE - Georgia 2
GR - Grecia 2
KH - Cambogia 2
MU - Mauritius 2
NO - Norvegia 2
OM - Oman 2
RO - Romania 2
TH - Thailandia 2
AW - Aruba 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CG - Congo 1
CR - Costa Rica 1
EE - Estonia 1
EU - Europa 1
GH - Ghana 1
IM - Isola di Man 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LV - Lettonia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
QA - Qatar 1
RS - Serbia 1
SI - Slovenia 1
SV - El Salvador 1
Totale 101.047
Città #
Cagliari 91.714
Uta 1.594
Ashburn 454
Singapore 452
Fairfield 328
San Jose 280
Woodbridge 216
Chandler 202
Nyköping 180
Boardman 163
Houston 161
Los Angeles 152
Ann Arbor 150
Beijing 128
Seattle 123
Dallas 116
Wilmington 115
Cambridge 106
Dearborn 82
Helsinki 79
New York 70
Jacksonville 65
Santa Clara 65
The Dalles 64
Council Bluffs 59
Hong Kong 56
Hanoi 49
Ho Chi Minh City 48
Lauterbourg 44
Shanghai 43
Hefei 42
Nanjing 31
Seoul 31
Frankfurt am Main 29
Dong Ket 28
London 28
Munich 25
Buffalo 24
Redwood City 23
Warsaw 23
Boston 22
Rome 22
Chicago 21
Milan 21
Brussels 20
São Paulo 20
Toronto 20
Kocaeli 19
San Mateo 19
Guangzhou 18
Johannesburg 18
Montreal 18
San Diego 18
Stockholm 17
Atlanta 16
Redondo Beach 16
Chennai 15
Denver 15
Orem 15
Phoenix 15
Casablanca 13
Pisa 13
Da Nang 12
Falls Church 12
Haiphong 12
Nuremberg 12
Turku 12
Amsterdam 11
Brooklyn 11
Jiaxing 11
Mountain View 11
Amman 10
Bari 10
Nanchang 10
Tokyo 10
Changsha 9
Dublin 9
Vienna 9
Baghdad 8
Manchester 8
Rio de Janeiro 8
Shenyang 8
Shenzhen 8
Tianjin 8
Augusta 7
Biên Hòa 7
Bogazici 7
Columbus 7
Dhaka 7
Düsseldorf 7
Florence 7
Leawood 7
Milwaukee 7
Norwalk 7
Poplar 7
Pune 7
Auburn Hills 6
Ferrara 6
Lappeenranta 6
Orange 6
Totale 98.360
Nome #
Thyroid hormone receptor ligands induce regression of rat preneoplastic liver lesions causing their reversion to a differentiated phenotype 6.018
Expression of c-jun is not mandatory for mouse hepatocyte proliferation induced by two nuclear receptor ligands: TCPOBOP and T3 4.977
Statistical health monitoring applied to a metabolomic study of experimental hepatocarcinogenesis: an alternative approach to supervised methods for the identification of false positives 4.264
Yes-associated protein regulation of adaptive liver enlargement and hepatocellular carcinoma development in mice 4.241
YAP activation is an early event and a potential therapeutic target in liver cancer development 4.055
Thyroid hormone (T3) and TRbeta agonist GC-1 inhibit/reverse nonalcoholic fatty liver in rats 3.964
Local hypothyroidism favors the progression of preneoplastic lesions to hepatocellular carcinoma in rats 3.882
TRbeta is the critical thyroid hormone receptor isoform in T3-induced proliferation of hepatocytes and pancreatic acinar cells 3.760
Cytokeratin-19 positivity is acquired along cancer progression and does not predict cell origin in rat hepatocarcinogenesis 3.715
Nrf2, but not β-catenin, mutation represents an early event in rat hepatocarcinogenesis 3.663
Emerging role of the pentose phosphate pathway in hepatocellular carcinoma 3.592
Global gene expression profile of normal and regenerating liver in young and old mice 3.568
Transcription profiling by array of mouse liver from TCPOBOP treated wild type and c-jun conditional knockout animals. 3.482
Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis 3.192
MicroRNA/gene profiling unveils early molecular changes and nuclear factor erythroid related factor 2 (NRF2) activation in a rat model recapitulating human hepatocellular carcinoma (HCC). 3.176
Induction of autophagy promotes the growth of early preneoplastic rat liver nodules 3.096
Reply to: "YAP in tumorigenesis: Friend or foe?" 2.769
High frequency of β-catenin mutations in mouse hepatocellular carcinomas induced by a nongenotoxic constitutive androstane receptor agonist 2.654
Reply to: Clinical correlation of miR-375 and alpha-fetoprotein in hepatocellular carcinoma: comparison in mice and humans 2.360
Accelerated entry into S phase and increased hepatocyte proliferation in c-jun conditional knock-out mice following administration of the CAR agonist TCPOBOP 2.351
Thyroid hormones, thyromimetics and their metabolites in the treatment of liver disease 2.332
Gender-specific interplay of signaling through β-catenin and CAR in the regulation of xenobiotic-induced hepatocyte proliferation 2.130
Human Leukocyte Antigen Complex and Other Immunogenetic and Clinical Factors Influence Susceptibility or Protection to SARS-CoV-2 Infection and Severity of the Disease Course. The Sardinian Experience 2.025
Animal models: A useful tool to unveil metabolic changes in hepatocellular carcinoma 1.671
Early metabolic changes in a liver carcinogenesis model 1.504
Design, synthesis and biological evaluation of novel TRβ selective agonists sustained by ADME-toxicity analysis 1.463
Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection 1.452
Thyroid hormone inhibits hepatocellular carcinoma progression via induction of differentiation and metabolic reprogramming 1.221
Early Metabolic Changes in preneoplastc nodules of the liver 1.180
Potential role of two novel agonists of thyroid hormone receptor-β on liver regeneration 971
Tg68, a novel thyroid hormone receptor‐β agonist for the treatment of NAFLD 971
Nrf2 Mutation/Activation Is Dispensable for the Development of Chemically Induced Mouse HCC 905
The density of hepatic autonomic innervation differs between compensatory and direct hyperplasia rat models 876
The double-sided of human leukocyte antigen-G molecules in type 1 autoimmune hepatitis 861
Distinct Mechanisms Are Responsible for Nrf2-Keap1 Pathway Activation at Different Stages of Rat Hepatocarcinogenesis 847
Effect of the ligands of thyroid hormone receptor on non-alcoholic fatty liver disease 843
Novel thyroid hormone receptor-beta agonist TG68 safely induces hepatic fat reduction in a non-alcoholic steatohepatitis rat model 753
mRNA-miRNA networks identify metabolic pathways associated to the anti-tumorigenic effect of thyroid hormone on preneoplastic nodules and hepatocellular carcinoma 705
Delta-globin gene expression improves sickle cell disease in a humanised mouse model 675
Novel thyroid hormone receptor-beta agonist TG68 safely induces hepatic fat reduction in a non-alcoholic steatohepatitis rat model 611
Diverse MicroRNAs-mRNA networks regulate the priming phase of mouse liver regeneration and of direct hyperplasia 524
Multi-Organ Morphological Findings in a Humanized Murine Model of Sickle Cell Trait 522
THYROID HORMONE INHIBITS HEPATOCELLULAR CARCINOMA (HCC) DEVELOPMENT BY INTERFERING WITH THE METABOLIC PROFILE OF CANCER CELLS 483
Sex difference in liver diseases: How preclinical models help to dissect the sex-related mechanisms sustaining NAFLD and hepatocellular carcinoma 468
Characterization Of Early Stage Metabolic Perturbations In A Rat Model Of Hepatocellular Carcinogenesis 436
Novel thyroid hormone receptor beta agonist TG68 safely induces hepatic fat loss reduction in a NASH mouse model 431
Novel thyroid hormone receptor-beta agonist TG68 safely induces hepatic fat reduction in a non-alcoholic steatohepatitis rat model 429
Potential use of TG68 - A novel thyromimetic - for the treatment of non-alcoholic fatty liver (NAFLD)-associated hepatocarcinogenesis 380
Metabolic reprogramming in Nrf2-driven proliferation of normal rat hepatocytes 333
Galectin-3 inhibition ameliorates hepatic steatosis in a multilineage 3D spheroid model 174
Estrogen-dependent activation of TRX2 reverses oxidative stress and metabolic dysfunction associated with steatotic disease 140
Lead induces cell-autonomous proliferation and metabolic reprogramming of hepatocytes 119
The role of OSM/OSMRβ axis in shaping the tumor microenvironment favoring MASLD-related HCC immune evasion 29
Totale 101.243
Categoria #
all - tutte 122.987
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 122.987


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021609 0 0 0 0 0 0 0 0 0 0 0 609
2021/20225.325 767 352 233 343 519 371 210 192 545 575 609 609
2022/20237.951 462 877 1.022 712 636 885 514 464 527 651 792 409
2023/20247.638 475 253 275 387 737 1.172 1.336 688 354 446 638 877
2024/202521.115 7.396 7.556 1.492 1.484 689 893 981 78 128 125 130 163
2025/20264.780 349 205 343 374 451 302 1.250 249 263 534 310 150
Totale 101.243